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Carroll et al. (2018. J. Cell Biol. https:// doi .org/ 10 .1083/ jcb .201708023) developed a method to assess DNA 
replication licensing in tissues. They show that intestinal stem cells within wild-type crypts, but not in crypts with 
cancer-causing mutations, are largely unlicensed, suggesting that licensing may represent a rate-limiting step 
in the commitment to proliferation.
DNA replication licensing in stem cells: Gatekeeping 
the commitment to proliferation
Hilary A. Coller
Many tissues contain quiescent stem cells that can be induced to 
enter the cell cycle and generate progeny called transit-ampli-
fying cells. These transit-amplifying cells proliferate and differ-
entiate to replenish cells that are lost or die. An understanding 
of the mechanisms that control stem cells’ decisions to enter the 
proliferative cell cycle would provide important insights into tis-
sue homeostasis and regeneration. One limitation in our under-
standing of the activation of quiescent stem cells has been the 
lack of markers and landmarks for quiescent cells. Although the 
progression through S phase, G2, and mitosis involves changes 
that are easily visible, the transition in and out of quiescence is 
not associated with easily detectable changes to cells. With few 
markers or indications of whether a cell is deeply quiescent or 
about to divide, it has been difficult to develop clear models for 
stem cell activation. Carroll et al. provide a new methodology to 
determine whether cells in the G0/G1 phase of the cell cycle have 
passed through a critical step in the commitment to proliferation: 
the translocation of the MCM2-7 proteins from the cytoplasm to 
origins of DNA replication (Carroll et al., 2018). Applying this 
methodology to intestinal crypts allowed Carroll et al. (2018) to 
discover that whereas proliferating cells have chromatin-asso-
ciated MCM2-7 proteins, stem cells mostly do not have MCM2-7 
bound to chromatin.
The synthesis of large eukaryotic genomes initiates at ori-
gins of replication, specific, designated locations. At these ori-
gins, DNA is unwound and made accessible to DNA polymerases 
(Blow and Hodgson, 2002). Although some proteins remain con-
tinuously bound to these origins, the double-hexamer complex 
of the MCM2-7 proteins translocates from the cytoplasm to the 
chromatin during the previous mitosis through the beginning 
of G1 (Blow and Dutta, 2005). The MCM2-7 complex must be 
activated by cyclin-dependent kinases for DNA replication to 
initiate. Because origin licensing cannot occur after the middle 
of G1, the same portions of DNA are not replicated more than 
once (Truong and Wu, 2011). By extracting cytoplasmic but not 
chromatin-bound MCM2-7, Carroll et al. (2018) determined 
whether individual cells in a tissue contain licensed DNA (Blow 
and Hodgson, 2002). This allowed them to establish a milestone 
marker within the largely unmarked G0/G1 phase of the cell 
cycle. It also allowed them to test the hypothesis that quiescent 
cells can be defined as nondividing cells in an unlicensed state 
(Blow and Hodgson, 2002; Coller, 2007).
The intestinal epithelium is a tissue that undergoes continu-
ous turnover to replenish lost cells. This replacement is largely 
performed by proliferating stem cells that differentiate into the 
epithelial cells that line the intestine. The most important source 
of these proliferative stem cells are stem cells that are mostly 
quiescent and divide only rarely when needed to replace the 
lost cells (Buczacki et al., 2013). The quiescent stem cells in the 
intestine mostly localize to the +4 position from the crypt base, 
are positive for stem cell marker Lgr5, and are negative for the 
secretory cell marker UAE. To better characterize the cell cycle 
in the different cell types within the crypt, Carroll et al. (2018) 
evaluated total Mcm2 levels as a marker for the Mcm2-7 complex 
in intestinal crypts. Mcm2 was expressed in Lgr5+ cells, the main 
proliferative stem cells that divide to replace lost cells, and was 
absent in the fully differentiated, secretory Paneth cells. Mcm2 
was also absent from the differentiated cells higher in the villi, 
consistent with a decline in the levels of Mcm2-7 proteins with 
differentiation (Eward et al., 2004).
The researchers then used their methodology to extract cyto-
plasmic Mcm2, while leaving Mcm2 bound to chromatin intact. 
They found that most Mcm2 had been removed, including from 
mitotic cells as expected, because Mcm2 is cytoplasmic during 
mitosis. Chromatin-bound Mcm2 was not present in differen-
tiated cells distal to the transit-amplifying cells, even cells that 
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were Ki-67 or EdU positive. The findings indicate that differen-
tiated cells, even if they are passing through a final cell cycle, 
are no longer licensed. In the crypt base, >50% of the Lgr5+ stem 
cells were unlicensed, whereas 30–40% of the Lgr5+ cells were 
actively cycling, likely representing currently amplifying stem 
cells. Using flow cytometry, Carroll et al. (2018) found that most 
Lgr5+ cells in crypts had low Mcm2-bound chromatin even if they 
had high Ki-67, indicating that licensing may be a more important 
determinant of cycling than other more commonly used mark-
ers. Their experimental data are most consistent with a model in 
which cells do not load MCM2-7 proteins until the cell has com-
mitted to cell cycle progression, at which time the protein com-
plex is rapidly loaded. Carroll et al. (2018) further distinguished 
among stem cells based on the recency of division. They activated 
expression of fluorescently labeled histone proteins and then 
turned off expression of these genes. Cells that remained fluo-
rescent 7 d later were cells that had not divided during the inter-
vening period and represented the most deeply quiescent cells in 
the crypt. These label-retaining cells had low levels of total Mcm2 
proteins. These deeply quiescent cells are thus dissimilar from 
the “active” intestinal stem cells. The label-retaining cells had low 
levels of total Mcm2 proteins, whereas the active stem cells had 
high levels of Mcm2 proteins that were not bound to chromatin; 
the active stem cells were thus poised but unlicensed.
To better understand the role of signaling pathways in the 
establishment of licensed and unlicensed states, Carroll et al. 
(2018) generated intestine-derived organoids. These organ-
oids had a higher fraction of cells with DNA-bound Mcm2 than 
was found in intestines, indicating that the stem cell niche in 
vivo may contribute to reducing the rate of licensing. Short-
term treatment of organoids with an inhibitor of EGF signaling 
resulted in cells accumulating in an unlicensed G1 state with 
high Mcm2 and Ki-67 but low chromatin-bound Mcm2. After 4 
d of EGF inhibition, cells maintained high total Mcm2, but there 
was a shift so that more cells had low Ki-67 expression. These 
findings suggest that EGF-based signaling may be important for 
the licensing of Mcm2.
Inspired by previous literature reporting that established cell 
lines lose the unlicensed G1 state and immediately license their 
origins upon exit from mitosis (Friedrich et al., 2005), Carroll et 
al. (2018) investigated the effects of loss of adenomatous polyp-
osis coli (APC), a protein that promotes degradation of β-catenin 
in the Wnt pathway (Stamos and Weis, 2013). APC loss is a fre-
quent early event in colorectal cancer (Kwong and Dove, 2009). 
Comparing organoids from WT mice and mice with mutations in 
the APC gene revealed that APC inactivation resulted in signifi-
cantly fewer unlicensed cells and more cells in the early phase 
of licensing. Carroll et al. (2018) sought to understand whether 
DNA licensing might be associated with the restriction point. 
The restriction point, defined as the point in the cell cycle after 
which a cell is irreversibly committed to divide, is thought to be 
enforced by phosphorylation of the retinoblastoma (Rb) pro-
tein. To determine whether the change in the fraction of cells 
with licensed origins with APC inactivation correlates with a 
change in the restriction point, Carroll et al. (2018) monitored 
the phosphorylation status of Rb. They found that although Rb 
proteins in cells in WT organoids were mostly hypophosphor-
ylated, there were significantly more hyperphosphorylated Rb 
proteins in cells in APC mutant organoids. The findings are con-
sistent with a connection between the Rb-based restriction point 
and origin licensing.
Collectively, Carroll et al. (2018) developed a method that 
allows them to monitor DNA licensing in intact crypts and organ-
oids. Their data reveal that there is a common state for stem cells 
of the intestine in which Mcm2 is expressed but has not trans-
located to chromatin. These cells can have high Ki-67, indicating 
that they have some of the markers of proliferative cells but are 
held in check by lack of licensing (Fig. 1). The findings by Carroll 
et al. (2018) raise the possibility that loading of MCM2-7 proteins 
to chromatin represents an important gatekeeping event for 
the transition between quiescence and proliferation. The find-
ings also suggest that the longer G0/G1 in stem cells reflects an 
extended unlicensed period. These findings are supported by the 
loss of the unlicensed state in cells with cancer-causing nonsense 
mutations in APC.
Carroll et al. (2018) raise many interesting questions for fur-
ther study. What is regulating the translocation of Mcm2-7 pro-
teins to chromatin? How do Mcm2 protein levels correlate with 
the levels of the E2F proteins? Are there unlicensed periods in 
the cell cycles of stem cells in other tissues, such as tissues that 
are less highly proliferative? Is there a role for DNA licensing in 
controlling the replication of other types of cells or only stem 
cells? Do all oncogenes, like APC, affect licensing and cause cells 
to remain continuously licensed? Is origin licensing important 
for other hyperproliferative cell states? The deeply G0 cells lost 
Mcm2 completely. Are there any landmarks that could be used to 
better classify deep G0?
Figure 1. An intestinal crypt is shown with markers for cell cycle phases. 
The base of the crypt is on the left of the image. G0, early G1, and G2 cells are 
indicated with a blue dye for nuclei. The methodology used by Carroll et al. 
(2018) to monitor chromatin-bound Mcm2 identifies cells in early G1 and is 
indicated in red. Cycling cells are positive for EdU and are indicated in green. 
Phospho–histone H3, a marker of M phase, is visualized as whitish dots. The 
majority of cells in the transit-amplifying compartment were positive for EdU, 
indicating that they were actively cycling. At the base of the crypt, most of the 
cells are unlicensed and are likely in G0. There are some cells with chroma-
tin-bound Mcm2 between the crypt base and the zone of actively proliferating 
EdU-positive cells. Image republished from Carroll et al. (2018) Fig. 3 A.
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